Skip to main content
. 2018 Oct 17;9:4316. doi: 10.1038/s41467-018-06618-y

Table 3.

Clinical information on the TTNtv and DSC2 loss-of-function carriers in the AF families

Family Pedigree ID Sex AF onset age Age Comorbidities/risk factors for AFa ECHO, at AF diagnosis or earliest available ECHO, latest available
LVDD (mm) LA (mm) LVEF(%) Years from AF diagnosis LVDD (mm) LA (mm) LVEF(%) Years from AF diagnosis
E003 II-2 M 42 62 Nb Sdb 40–45c 16 Nb 40 55 18
E003 II-5 F 58 71 HTN, HT Nb 45 Nb 4 Nb Sdb Nb 10
E003 III-4 M 37 47 NIDCM 67 57 15 0 70 56 30–35 8
M1023 II-4 F 63 71 Nb Nb 35c 0 60 32 25c 7
M1023 III-1 M 40 50 NIDCM 67–71 51 20 3 54 44 43c 11
M1023 III-3 F 25 52 49 38 66 22 56 44 25c 27
M1018 III-1 M 65 69 Multid Sdb Sdb Nb 0 Mild CLVHb Db 60 3
M1018 IV-2 M 28 38 HTN Nb Nb Nb 0 Nb Nb Nb 0
M1018 IV-3 M 31 40 Nb 34 Nb 0 Nb Nb 60 7
M1039 III-2 M 23 50 Nb Nb Nb 16 55 Nb 60 24
M1039 III-3 M 39 51 NIDCM Sdb N.A. 30c 5 Moderat Db Nb 50–55 8
M1039 III-5 M 25 37 Nb Nb Nb 9 Nb Nb 60 11
M1030 III-4 M 49 63 HCL Nb Db Nb 0 Nb Db Nb 0
M1030 III-7 F 50 72 Mild H Mild Db Nb 10 Mild H Mild Db Nb 0
M1030 IV-5 M 41 46 52 43 Nb 0 52 43 Nb 0

AF:  atrial fibrillation, LVDD:   left ventricular diastolic diameter, LA:  left atrial diameter, LVEF(%):  left ventricular ejection fraction (%), D:   dilated, H:  hypertrophy, HT:  hyperthyroidism, HTN:  hypertension, HCL:  hypercholesterolemia, NIDCM: nonischemic dilated cardiomyopathy, M/F:  male/female, N:  normal, Sd:  severely dilated, CLVH:  concentric left ventricular hypertrophy, TTN:  titin, TTNtv:  titin-truncating variants, DSC2:  desmocollin 2, N.A.:  not available, ECHO: echocardiography

aDiagnosed before or within 12 months after the AF diagnosis

bExact values not provided

cDuring AF

dHypertension, stroke, aortic-, and mitral prolapse and regurgitation (biological aortic valve and mitral valve repair), dilated LV